Histrelin Implant (Prostate Cancer) and Methylphenidate Extended-Release Tablets
Determining the interaction of Histrelin Implant (Prostate Cancer) and Methylphenidate Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin Implant (Prostate Cancer)-Methylphenidate Hydrochloride
- Histrelin Implant (Prostate Cancer)-Methylphenidate LA Capsules
- Histrelin Implant (Prostate Cancer)-Methylphenidate Oral Solution
- Histrelin Implant (Prostate Cancer)-Methylphenidate Oral, Transdermal
- Histrelin Implant (Prostate Cancer)-Methylphenidate Tablets
- Histrelin Implant (Prostate Cancer)-Methylphenidate transdermal
- Methylphenidate Extended-Release Tablets-Histrelin Subcutaneous
- Methylphenidate Extended-Release Tablets-Histuss PD
- Methylphenidate Extended-Release Tablets-Hivid
- Methylphenidate Extended-Release Tablets-Hizentra
- Methylphenidate Extended-Release Tablets-HMS
- Methylphenidate Extended-Release Tablets-Hold